300146 Cost Of Revenue from 2010 to 2024

300146 Stock   12.35  0.19  1.56%   
By Health's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 3.1 B this year. From 2010 to 2024 By Health Cost Of Revenue quarterly data regression line had arithmetic mean of  1,384,942,840 and r-squared of  0.96. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-09-30
Previous Quarter
654 M
Current Value
388.6 M
Quarterly Volatility
244.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check By Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among By Health's main balance sheet or income statement drivers, such as Interest Expense of 6.6 M, Selling General Administrative of 3.5 B or Total Revenue of 9.9 B, as well as many indicators such as . 300146 financial statements analysis is a perfect complement when working with By Health Valuation or Volatility modules.
  
This module can also supplement various By Health Technical models . Check out the analysis of By Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in 300146 Stock

By Health financial ratios help investors to determine whether 300146 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 300146 with respect to the benefits of owning By Health security.